MEC Plus Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Plus Events — 2025 MaTOS Breast 2025 MaTOS GU 2025 MCM 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MCM 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Type of Media — Video Document Audio Author / Speaker Title Search Entries: « 1 … 49 50 51 52 53 … 100 » Castration Resistant Prostate Cancer: What is the Optimal Treatment? Sarmad Sadeghi, MD, PhD View Video Castration Resistant Prostate Cancer: What is the Optimal Treatment? Sarmad Sadeghi, MD, PhD View PDF State of the Art: Hormone-sensitive Prostate Cancer Primo N. Lara, Jr., MD View Video State of the Art: Hormone-sensitive Prostate Cancer Primo N. Lara, Jr., MD View PDF Advance in Treatment of Acute Lymphocyctic Leukemia George Yaghmour, MD View Video Advance in Treatment of Acute Lymphocyctic Leukemia George Yaghmour, MD View PDF Lymphoma: State of the Art Joseph M. Tuscano, MD View PDF Lymphoma: State of the Art Joseph M. Tuscano, MD View Video AML and MDS: Current Status and Future Directions Brian A. Jonas, MD, PhD, FACP View Video AML and MDS: Current Status and Future Directions Brian A. Jonas, MD, PhD, FACP View PDF The Future of Combined Modality Therapy Everett E. Vokes, MD View Video The Future of Combined Modality Therapy Everett E. Vokes, MD View PDF Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View Video Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View PDF Advances in Small Cell Lung Cancer and Mesothelioma Ravi Salgia, MD, PhD View Video Advances in Small Cell Lung Cancer and Mesothelioma Ravi Salgia, MD, PhD View PDF Updates in Targeted Therapy for NSCLC Jonathan W. Riess, MD. MS View Video Updates in Targeted Therapy for NSCLC Jonathan W. Riess, MD. MS View PDF Updates in Immunotherapy for Lung Cancer Jorge J. Nieva, MD View Video Updates in Immunotherapy for Lung Cancer Jorge J. Nieva, MD View PDF Esophageal and Gastric Cancer: New Developments Syma Iqbal, MD View Video Esophageal and Gastric Cancer: New Developments Syma Iqbal, MD View PDF Colorectal Cancer: State of the Art Heinz-Josef Lenz, MD, FACP View Video Colorectal Cancer: State of the Art Heinz-Josef Lenz, MD, FACP View PDF Pancreatic Cancer: Emerging Strategies Vincent Chung, MD View Video Pancreatic Cancer: Emerging Strategies Vincent Chung, MD View PDF Advances in Car-T Cells and Other Cellular Based Therapies Elizabeth Budde, MD, PhD View Video Advances in Car-T Cells and Other Cellular Based Therapies Elizabeth Budde, MD, PhD View PDF Management of Immune Related Adverse Events Elizabeth (Liz) Cooke, RN, NP, PhD View Video Management of Immune Related Adverse Events Elizabeth (Liz) Cooke, RN, NP, PhD View PDF ← Previous View We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
